Pre-Clinical Characterization of a Novel Fusion Protein (AT-03), with Pan-Amyloid Binding and Removal
Christophe Sirac(Centre National de la Recherche Scientifique), Jonathan S. Wall(University of Tennessee at Knoxville), Gregory D. Bell, Sébastien Bender(Centre National de la Recherche Scientifique), Suganya Selvarajah, Roussine Codo(Centre National de la Recherche Scientifique), Spencer Guthrie(Heidelberg University), Gemma Martinez-Rivas(Hôpital Dupuytren), Frank Bridoux(Université de Poitiers), Angela Williams(University of Tennessee Medical Center), Arnaud Jaccard(Centre Hospitalier Universitaire de Limoges), James S. Foster(University of Tennessee Health Science Center), Stephen J. Kennel(University of Tennessee at Knoxville)
Cited by 12
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
|Journal of Clinical Oncology|2012|965
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809
Integrin alpha 6/beta 4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion.
|The Journal of Cell Biology|1991|577